SCHEMBL6094726

SCHEMBL6094726

CCCN1CCN(c2cc(C)c3nc(-c4c(NCC(O)c5cccc(Cl)c5)cc[nH]c4=O)[nH]c3c2)CC1

nearest known ligand 0.91

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 20/20 0.91
CYP3A4 P08684 19/20 0.91
EGFR P00533 2/20 0.82
INSR P06213 2/20 0.82
LCK P06239 2/20 0.82
KDR P35968 2/20 0.82
PTK2 Q05397 2/20 0.82
ERBB2 P04626 1/20 0.82
CYP1A2 P05177 1/20 0.82
MET P08581 1/20 0.82
CYP2C9 P11712 1/20 0.82
CYP2C19 P33261 1/20 0.82
MAP2K1 Q02750 1/20 0.82
PLK4 O00444 1/20 0.82
CHEK1 O14757 1/20 0.82
AURKA O14965 1/20 0.82
PDPK1 O15530 1/20 0.82
DAPK3 O43293 1/20 0.82
DYRK3 O43781 1/20 0.82
JAK2 O60674 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4121364 0.95 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL3996217 0.95 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL4004423 0.94 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL5137297 0.94 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL4005273 0.94 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL5512745 0.93 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL4006921 0.93 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL5182632 0.93 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL5182628 0.93 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK
SCHEMBL5182647 0.93 IGF1R (1.00) IGF1RCYP3A4EGFRINSRLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223757-B2 Tyrosine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-29 US disclosed
US-7223757-B2 Tyrosine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-29 US disclosed
US-7081454-B2 Tyrosine kinase inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2006-07-25 US disclosed